For example, if you have hives caused by a virus or bacterial infection, a person can contract the virus and also develop hives. Taking steps to avoid the spread of infection may help prevent hives.

Cholinergic urticaria are heat-related hives that cause raised, red spots or an itchy rash. They can occur anywhere on the body (though the neck and chest are common) and typically lead to itching.

In phase 3 trials, dupilumab significantly reduced itch and hives compared with placebo. The Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adult and ...

In phase 3 trials, dupilumab significantly reduced itch and hives compared with placebo. The Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adult and ...

Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria for up to 8% of the population. Hives tend to ...

1 The chikungunya virus (CHIKV), an alphavirus ... structures within these spherules have been characterized, the full structure of the organelle is still not fully understood.

Key presentations on chronic spontaneous urticaria (CSU) at the American Academy of Dermatology 2025 include late-breaking data on the anti-c-Kit antibody briquilimab and positive results for ...

Here's how to relieve the itching and get steps on preventing hives and avoiding your triggers. As small as jujubes or as large as saucers, hives are an allergic reaction that take the form of itchy ...

Are hives bugging you day and night? You don’t have to put up with the itch.

Itchy, raised bumps caused by hives can look different on medium and dark skin tones. Instead of pink, they may be the same color as the skin. Hives is a common condition that causes itchy ...

Phase 3 trials showed significant reductions in itch and urticaria severity with dupilumab compared to placebo at week 24. Dupilumab offers a new treatment option for CSU, being the first targeted ...

Dupilumab was approved for treatment of chronic spontaneous urticaria in patients aged 12 years and older. Several studies reported reduced itch severity and urticaria activity with dupilumab.